Global Liquid Biopsy Market – Analysis and Forecast (2025-2030) Industry Insights by Product and Services (Assay Kits, Services, and Instruments), by Circulating Biomarker (Circulating Tumor Cells, Extracellular Vesicles (Evs), Circulating Tumor DNA (CTDNA), Cell-Free DNA, and Other Circulating Biomarkers), by Clinical Application (Early Cancer Screening, Treatment Monitoring, Recurrence Monitoring, and Therapy Selection), by Application (Cancer Applications (Liver Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Breast Cancer, and Other Cancers) and Non-Cancer Applications) and by End User (Reference Laboratories, Academic and Research Centers, Hospitals and Physician Laboratories, and Other End Users), by Geography (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Japan, China, India, Australia, South Korea, Brazil, Argentina, South Africa, Saudi Arabia)